10-K Filing

BENITEC BIOPHARMA INC. CIK: 1808898 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001193125-20-252381`
Period End Date	20200630
Filing Date	20200923
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	bntc-20200630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 49 Income Statement 37 Cash Flow Statement 42 Stockholders Equity 15

Balance Sheet 49 line items

Line Item	Tag	Value	Unit	Period
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	10.00M	shares	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.72M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	856,765.00	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	1.11M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.88M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.80M	USD	Point-in-time
Trade and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$59.00K	USD	Point-in-time
Trade and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$2.54M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	856,765.00	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	1.11M	shares	Point-in-time
Other assets	`OtherAssetsCurrent`	$502.00K	USD	Point-in-time
Other assets	`OtherAssetsCurrent`	$949.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.81M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$18.76M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$470.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$374.00K	USD	Point-in-time
Deposits	`DepositAssets`	$9.00K	USD	Point-in-time
Deposits	`DepositAssets`	$9.00K	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$395.00K	USD	Point-in-time
Total assets	`Assets`	$11.59M	USD	Point-in-time
Total assets	`Assets`	$19.23M	USD	Point-in-time
Trade and other payables	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.49M	USD	Point-in-time
Trade and other payables	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$741.00K	USD	Point-in-time
Accrued employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$203.00K	USD	Point-in-time
Accrued employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$147.00K	USD	Point-in-time
Lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$192.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.14M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.64M	USD	Point-in-time
Lease liabilities, less current portion	`OperatingLeaseLiabilityNoncurrent`	$213.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.35M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.64M	USD	Point-in-time
Commitments and contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.0001 par value10,000,000 shares authorized; 1,108,374 and 856,765 shares issued and outstanding at June 30, 2020 and 2019, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Common stock, $0.0001 par value10,000,000 shares authorized; 1,108,374 and 856,765 shares issued and outstanding at June 30, 2020 and 2019, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$128.83M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$127.33M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-116.64M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-108.87M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.86M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.59M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.24M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$13.84M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$11.59M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$19.23M	USD	Point-in-time

Income Statement 37 line items

Line Item	Tag	Value	Unit	Period
Revenues from customers	`RevenueFromContractWithCustomerIncludingAssessedTax`	$11.55M	USD	Annual
Revenues from customers	`RevenueFromContractWithCustomerIncludingAssessedTax`	$97.00K	USD	Annual
Government research and development grants	`RevenueNotFromContractWithCustomerOther`	$648.00K	USD	Annual
Government research and development grants	`RevenueNotFromContractWithCustomerOther`	$5.00K	USD	Annual
Total revenues	`Revenues`	$102.00K	USD	Annual
Total revenues	`Revenues`	$12.20M	USD	Annual
Royalties and license fees	`RoyaltiesAndLicenseFees`	$435.00K	USD	Annual
Royalties and license fees	`RoyaltiesAndLicenseFees`	$-185.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$4.57M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.00M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$4.61M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$5.57M	USD	Annual
Total operating expenses	`OperatingExpenses`	$9.62M	USD	Annual
Total operating expenses	`OperatingExpenses`	$8.38M	USD	Annual
Income (loss) from operations	`OperatingIncomeLoss`	$2.58M	USD	Annual
Income (loss) from operations	`OperatingIncomeLoss`	$-8.28M	USD	Annual
Foreign currency transaction loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-75.00K	USD	Annual
Foreign currency transaction loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-88.00K	USD	Annual
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$122.00K	USD	Annual
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$62.00K	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$34.00K	USD	Annual
Unrealized loss on investment	`UnrealizedGainLossOnInvestments`	$-21.00K	USD	Annual
Unrealized loss on investment	`UnrealizedGainLossOnInvestments`	$-1.00K	USD	Annual
Total other income, net	`NonoperatingIncomeExpense`	$26.00K	USD	Annual
Total other income, net	`NonoperatingIncomeExpense`	$7.00K	USD	Annual
Net income (loss)	`NetIncomeLoss`	$2.61M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-8.27M	USD	Annual
Unrealized foreign currency translation loss	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-89.00K	USD	Annual
Unrealized foreign currency translation loss	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-531.00K	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-89.00K	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-531.00K	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$2.08M	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-8.36M	USD	Annual
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-8.10	USD	Annual
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$3.05	USD	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.02M	shares	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	856,765.00	shares	Annual

Cash Flow Statement 42 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$2.61M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-8.27M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$190.00K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$158.00K	USD	Annual
Amortization of right-of-use assets	`AmortizationOfRightOfUseAssets`	$184.00K	USD	Annual
Loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-7.00K	USD	Annual
Loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.00K	USD	Annual
Unrealized loss on investment	`UnrealizedGainLossOnInvestments`	$-21.00K	USD	Annual
Unrealized loss on investment	`UnrealizedGainLossOnInvestments`	$-1.00K	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$672.00K	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$237.00K	USD	Annual
Trade and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-2.40M	USD	Annual
Trade and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-607.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$457.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$9.00K	USD	Annual
Trade and other payables	`IncreasedecreaseInAccountsAndOtherPayables`	$-1.70M	USD	Annual
Trade and other payables	`IncreasedecreaseInAccountsAndOtherPayables`	$740.00K	USD	Annual
Accrued employee benefit payable	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$57.00K	USD	Annual
Accrued employee benefit payable	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-15.00K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiabilities`	$-174.00K	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.54M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.79M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$404.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$95.00K	USD	Annual
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$4.00K	USD	Annual
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$1.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-94.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-400.00K	USD	Annual
Proceeds from issues of shares	`ProceedsFromIssuanceOfCommonStock`	$2.25M	USD	Annual
Share issue transaction costs	`PaymentsOfStockIssuanceCosts`	$480.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.77M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$4.39M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-5.86M	USD	Annual
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$15.72M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$11.88M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$9.80M	USD	Point-in-time
Effects of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-58.00K	USD	Annual
Effects of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-551.00K	USD	Annual
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$15.72M	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$11.88M	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$9.80M	USD	Point-in-time
Initial measurement of operating lease right-of-use assets and liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$579.00K	USD	Annual

Stockholders Equity 15 line items

Line Item	Tag	Value	Unit	Period
Payments For Stock Issuance Costs	`PaymentsOfStockIssuanceCosts`	$480.00K	USD	Annual
Balance at the beginning	`StockholdersEquity`	$16.59M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$10.24M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$13.84M	USD	Point-in-time
Common stock sold for cash, net of offering costs of $240	`StockIssuedDuringPeriodValueNewIssues`	$1.72M	USD	Annual
Issuance and exercise of pre-funded warrants, net of transaction costs of $240	`IssuanceAndExerciseOfPrefundedWarrantsNetOfTransactionCosts`	$50.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$672.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$237.00K	USD	Annual
Foreign currency translation loss	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-89.00K	USD	Annual
Foreign currency translation loss	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-531.00K	USD	Annual
Net income (loss)	`NetIncomeLoss`	$2.61M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-8.27M	USD	Annual
Balance at end	`StockholdersEquity`	$16.59M	USD	Point-in-time
Balance at end	`StockholdersEquity`	$10.24M	USD	Point-in-time
Balance at end	`StockholdersEquity`	$13.84M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.